Skip to Content

MS Public Seminar: CINDY YAMILET CANALES

When & Where

April 25
1:30 PM - 2:30 PM
UTHealth Houston, McGovern Medical School, MSB B.610 and Microsoft Teams (View in Google Map)

Contact

Event Description

Denial of Inpatient Testing: A Study on Outpatient Yield and Outcomes 

Cindy Yamilet Canales, BS (Advisor: Kathryn Gunther Leal, MS, CGC)

          This study investigates the difference in diagnostic yield between patients approved for inpatient genetic testing compared to those denied inpatient testing and the effect of an earlier diagnosis on outcomes and medical/clinical care. In the literature, research has explored the impact of a diagnostic delay for patients with genetics conditions, assessed the utility of genetic testing in the inpatient setting, and described the impact to care of an earlier diagnosis. However, gaps remain on research exploring the diagnostic yields of inpatient versus outpatient settings and the potential impact to care an inpatient genetic testing request denial may pose. This is the first study to determine if denial of inpatient genetic testing leads to a diagnostic delay and delay in subsequent medical services that impact care. This study reviewed 1,052 charts of patients admitted inpatient who received a genetics consult between July 2018 and June 2023. Data was collected on recommendations for genetic testing, completion of genetic testing, results of genetic testing, and management recommendations based on a diagnosis. Statistical data analysis was completed to identify differences between inpatient and outpatient groups. The results indicated the outpatient group had 2x higher diagnostic yield and a 6-month diagnostic delay compared to the inpatient group. Management recommendations did not differ between the groups suggesting a subsequent delay to changes in care. In addition, public insurance holders took 3 weeks longer to attend the outpatient clinic and public insurance holders were 28% more likely to be approved for inpatient genetic testing. Inclusion of genetic providers in the review of inpatient genetic testing requests should be considered to improve inpatient and outpatient outcomes.

Advisory Committee:

  • Kathryn Gunther Leal, MS, CGC, Chair
  • Meagan Choates, MS, CGC
  • Laura Farach, MD
  • Paul Hillman, MD, PhD
  • Kathleen Shields, MS, CGC
  • Theresa Wittman, MS, CGC

Join via Microsoft Teams (Please contact Ms. Cindy Canales for her Microsoft Teams info.) 

{ "name":"MS Public Seminar: CINDY YAMILET CANALES", "description":"

Denial of Inpatient Testing: A Study on Outpatient Yield and Outcomes 

Cindy Yamilet Canales, BS (Advisor: Kathryn Gunther Leal, MS, CGC)

          This study investigates the difference in diagnostic yield between patients approved for inpatient genetic testing compared to those denied inpatient testing and the effect of an earlier diagnosis on outcomes and medical/clinical care. In the literature, research has explored the impact of a diagnostic delay for patients with genetics conditions, assessed the utility of genetic testing in the inpatient setting, and described the impact to care of an earlier diagnosis. However, gaps remain on research exploring the diagnostic yields of inpatient versus outpatient settings and the potential impact to care an inpatient genetic testing request denial may pose. This is the first study to determine if denial of inpatient genetic testing leads to a diagnostic delay and delay in subsequent medical services that impact care. This study reviewed 1,052 charts of patients admitted inpatient who received a genetics consult between July 2018 and June 2023. Data was collected on recommendations for genetic testing, completion of genetic testing, results of genetic testing, and management recommendations based on a diagnosis. Statistical data analysis was completed to identify differences between inpatient and outpatient groups. The results indicated the outpatient group had 2x higher diagnostic yield and a 6-month diagnostic delay compared to the inpatient group. Management recommendations did not differ between the groups suggesting a subsequent delay to changes in care. In addition, public insurance holders took 3 weeks longer to attend the outpatient clinic and public insurance holders were 28% more likely to be approved for inpatient genetic testing. Inclusion of genetic providers in the review of inpatient genetic testing requests should be considered to improve inpatient and outpatient outcomes.

Advisory Committee:

  • Kathryn Gunther Leal, MS, CGC, Chair
  • Meagan Choates, MS, CGC
  • Laura Farach, MD
  • Paul Hillman, MD, PhD
  • Kathleen Shields, MS, CGC
  • Theresa Wittman, MS, CGC

Join via Microsoft Teams (Please contact Ms. Cindy Canales for her Microsoft Teams info.) 

", "startDate":"2025-4-25", "endDate":"2025-4-25", "startTime":"13:30", "endTime":"14:30", "location":"UTHealth Houston, McGovern Medical School, MSB B.610 and Microsoft Teams", "label":"Add to Calendar", "options":[ "Apple", "Google", "iCal", "Microsoft365", "MicrosoftTeams", "Yahoo" ], "timeZone":"America/Chicago", "trigger":"click", "inline":true, "listStyle":"modal", "iCalFileName":"Reminder-Event" }